Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/7493

TDMS Study 88138-04 Pathology Tables

NTP Experiment-Test: 88138-04         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            BENZOPHENONE                                       Date: 06/01/04
Route: DOSED FEED                                                                                                 Time: 13:24:25

                                                          FINAL#2 MICE




       Facility:  Battelle Columbus Laboratory

       Chemical CAS #:  119-61-9

       Lock Date:  04/26/02

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All


































a  Number of animals examined microscopically at site and number of animals with lesion

                                                              Page   1


NTP Experiment-Test: 88138-04         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                            BENZOPHENONE                                       Date: 06/01/04    
Route: DOSED FEED                                                                                                 Time: 13:24:25    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE FEMALE                        0 PPM        312 PPM      625 PPM      1250 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
DISPOSITION SUMMARY                                                                                                                 
                                                                                                                                    
  Animals Initially In Study                          50           50           50           50                                     
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                 4            2            5            6                                     
    Natural Death                                      6            6            4           12                                     
    Accidently Killed                                                                         1                                     
  Survivors                                                                                                                         
    Terminal Sacrifice                                40           42           41           31                                     
                                                                                                                                    
  Animals Examined Microscopically                    50           50           50           50                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Gallbladder                                        (49)         (50)         (50)         (50)                                   
      Cyst                                                          1 (2%)       1 (2%)                                             
      Infiltration Cellular, Lymphoid                                            1 (2%)                                             
      Inflammation, Chronic Active                     1 (2%)                    1 (2%)       1 (2%)                                
      Mineralization                                                             1 (2%)                                             
   Intestine Large, Colon                             (50)         (50)         (50)         (50)                                   
      Inflammation, Chronic Active                                                            1 (2%)                                
   Intestine Small, Duodenum                          (50)         (50)         (50)         (50)                                   
      Inflammation, Chronic Active                                               1 (2%)                                             
   Intestine Small, Jejunum                           (50)         (50)         (50)         (50)                                   
      Peyer's Patch, Hyperplasia, Lymphoid                          3 (6%)                    1 (2%)                                
   Intestine Small, Ileum                             (50)         (50)         (50)         (50)                                   
      Peyer's Patch, Hyperplasia, Lymphoid                          1 (2%)                                                          
   Liver                                              (50)         (50)         (50)         (50)                                   
      Angiectasis                                      2 (4%)                    1 (2%)       4 (8%)                                
      Basophilic Focus                                 3 (6%)                    1 (2%)       2 (4%)                                
      Clear Cell Focus                                 3 (6%)       2 (4%)       4 (8%)       4 (8%)                                
      Eosinophilic Focus                               2 (4%)       2 (4%)       7 (14%)      7 (14%)                               
      Hematopoietic Cell Proliferation                18 (36%)     11 (22%)     20 (40%)     19 (38%)                               
      Infarct                                                                                 1 (2%)                                
      Infiltration Cellular, Lymphoid                 36 (72%)     38 (76%)     35 (70%)     35 (70%)                               
      Inflammation, Chronic Active                    44 (88%)     40 (80%)     41 (82%)     36 (72%)                               
      Mineralization                                                             1 (2%)                                             
      Mixed Cell Focus                                 2 (4%)       5 (10%)      3 (6%)       2 (4%)                                
      Tension Lipidosis                                4 (8%)       8 (16%)      3 (6%)       7 (14%)                               
      Bile Duct, Hyperplasia                           1 (2%)                                                                       
      Hepatocyte, Autolysis                                                                   1 (2%)                                
      Hepatocyte, Mitotic Alteration                                             1 (2%)                                             
      Hepatocyte, Multinucleated                                                              2 (4%)                                
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    2                                                              
                                                                                                                                   
NTP Experiment-Test: 88138-04         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                            BENZOPHENONE                                       Date: 06/01/04    
Route: DOSED FEED                                                                                                 Time: 13:24:25    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE FEMALE                        0 PPM        312 PPM      625 PPM      1250 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Hepatocyte, Necrosis                             3 (6%)       5 (10%)      4 (8%)                                             
      Hepatocyte, Vacuolization Cytoplasmic           41 (82%)     43 (86%)     39 (78%)     34 (68%)                               
      Hepatocyte, Centrilobular, Degeneration                                                 1 (2%)                                
      Hepatocyte, Centrilobular, Hypertrophy                       29 (58%)     44 (88%)     37 (74%)                               
   Mesentery                                          (6)          (9)          (11)         (9)                                    
      Fat, Fibrosis                                    1 (17%)      2 (22%)      8 (73%)      4 (44%)                               
      Fat, Hemorrhage                                                                         1 (11%)                               
      Fat, Infiltration Cellular, Lymphoid                                       4 (36%)                                            
      Fat, Inflammation, Chronic Active                1 (17%)      3 (33%)      7 (64%)      3 (33%)                               
      Fat, Mineralization                                           1 (11%)      2 (18%)      1 (11%)                               
      Fat, Necrosis                                    1 (17%)      4 (44%)      9 (82%)      4 (44%)                               
   Pancreas                                           (50)         (50)         (50)         (50)                                   
      Cyst                                             1 (2%)       2 (4%)                                                          
      Infiltration Cellular, Lymphoid                 20 (40%)     24 (48%)     33 (66%)     18 (36%)                               
      Acinus, Atrophy                                  1 (2%)       1 (2%)       1 (2%)       2 (4%)                                
      Acinus, Cytoplasmic Alteration                                1 (2%)                                                          
      Duct, Inflammation, Chronic Active                                         1 (2%)                                             
      Duct, Pigmentation                                                         1 (2%)                                             
   Salivary Glands                                    (50)         (50)         (50)         (50)                                   
      Infiltration Cellular, Lymphoid                 27 (54%)     34 (68%)     30 (60%)     28 (56%)                               
   Stomach, Forestomach                               (50)         (50)         (50)         (50)                                   
      Inflammation, Chronic Active                     1 (2%)                                 1 (2%)                                
      Epithelium, Hyperkeratosis                       1 (2%)       1 (2%)       1 (2%)       1 (2%)                                
      Epithelium, Hyperplasia, Squamous                1 (2%)       1 (2%)                    1 (2%)                                
      Epithelium, Ulcer                                1 (2%)                                 1 (2%)                                
   Stomach, Glandular                                 (50)         (50)         (50)         (50)                                   
      Epithelium, Glands, Hyperplasia                  1 (2%)                                                                       
      Glands, Ectasia                                 18 (36%)     16 (32%)     22 (44%)     10 (20%)                               
      Glands, Mineralization                                        3 (6%)                    2 (4%)                                
   Tooth                                              (21)         (29)         (24)         (20)                                   
      Malformation                                                               1 (4%)                                             
      Gingiva, Inflammation, Chronic Active           21 (100%)    29 (100%)    24 (100%)    20 (100%)                              
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Blood Vessel                                       (50)         (50)         (50)         (50)                                   
      Aorta, Mineralization                                                                   1 (2%)                                
   Heart                                              (50)         (50)         (50)         (50)                                   
      Cardiomyopathy                                                             1 (2%)                                             
      Hyperplasia, Atypical                                                      1 (2%)       1 (2%)                                
      Inflammation, Chronic Active                     2 (4%)       1 (2%)       1 (2%)                                             
      Mineralization                                                             1 (2%)                                             
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    3                                                              
                                                                                                                                   
NTP Experiment-Test: 88138-04         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                            BENZOPHENONE                                       Date: 06/01/04    
Route: DOSED FEED                                                                                                 Time: 13:24:25    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE FEMALE                        0 PPM        312 PPM      625 PPM      1250 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
CARDIOVASCULAR SYSTEM - CONT                                                                                                        
      Necrosis                                         1 (2%)                                                                       
      Valve, Inflammation, Chronic Active              1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (50)         (50)         (50)         (49)                                   
      Accessory Adrenal Cortical Nodule                1 (2%)                                 1 (2%)                                
      Hematopoietic Cell Proliferation                 1 (2%)                                 1 (2%)                                
      Hemorrhage                                                                              1 (2%)                                
      Hyperplasia                                      2 (4%)                                                                       
      Hypertrophy                                      1 (2%)       1 (2%)                                                          
      Inflammation, Chronic Active                     1 (2%)                                                                       
      Mineralization                                                                          1 (2%)                                
      Necrosis                                                      1 (2%)                    1 (2%)                                
      Subcapsular, Hyperplasia                        49 (98%)     49 (98%)     49 (98%)     49 (100%)                              
   Adrenal Medulla                                    (50)         (50)         (50)         (49)                                   
      Hyperplasia                                                                2 (4%)                                             
   Islets, Pancreatic                                 (50)         (50)         (50)         (50)                                   
      Hyperplasia                                      3 (6%)       1 (2%)                                                          
   Parathyroid Gland                                  (42)         (41)         (40)         (40)                                   
      Cyst                                                                       3 (8%)       1 (3%)                                
   Pituitary Gland                                    (50)         (50)         (49)         (47)                                   
      Pars Distalis, Angiectasis                       2 (4%)       4 (8%)       5 (10%)      3 (6%)                                
      Pars Distalis, Cyst                              5 (10%)      3 (6%)       2 (4%)                                             
      Pars Distalis, Hyperplasia                      14 (28%)     14 (28%)     13 (27%)      3 (6%)                                
      Pars Distalis, Hypertrophy                                                 1 (2%)                                             
      Pars Distalis, Pigmentation                                                1 (2%)                                             
   Thyroid Gland                                      (50)         (50)         (50)         (50)                                   
      Infiltration Cellular, Lymphoid                               1 (2%)       2 (4%)       2 (4%)                                
      Inflammation, Chronic Active                                  1 (2%)       2 (4%)                                             
      C-Cell, Hyperplasia                                                                     1 (2%)                                
      Follicle, Cyst                                                1 (2%)                                                          
      Follicle, Degeneration                          17 (34%)     19 (38%)     12 (24%)      9 (18%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    4                                                              
                                                                                                                                   
NTP Experiment-Test: 88138-04         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                            BENZOPHENONE                                       Date: 06/01/04    
Route: DOSED FEED                                                                                                 Time: 13:24:25    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE FEMALE                        0 PPM        312 PPM      625 PPM      1250 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
GENITAL SYSTEM - CONT                                                                                                               
   Clitoral Gland                                     (50)         (49)         (50)         (50)                                   
      Inflammation, Chronic Active                     8 (16%)      1 (2%)                    2 (4%)                                
      Duct, Cyst                                       1 (2%)                                                                       
   Ovary                                              (49)         (50)         (50)         (50)                                   
      Angiectasis                                      1 (2%)       1 (2%)                                                          
      Atrophy                                         48 (98%)     48 (96%)     46 (92%)     45 (90%)                               
      Cyst                                            22 (45%)     17 (34%)     17 (34%)     14 (28%)                               
      Hemorrhage                                       2 (4%)       5 (10%)      3 (6%)       4 (8%)                                
      Infiltration Cellular, Lymphoid                                                         1 (2%)                                
      Inflammation, Chronic Active                     2 (4%)       1 (2%)       1 (2%)                                             
      Mineralization                                                4 (8%)       2 (4%)                                             
      Pigmentation                                     6 (12%)      2 (4%)       3 (6%)       1 (2%)                                
   Uterus                                             (49)         (50)         (50)         (50)                                   
      Angiectasis                                      1 (2%)                    1 (2%)                                             
      Inflammation, Chronic Active                     5 (10%)      4 (8%)       2 (4%)       2 (4%)                                
      Endometrium, Hyperplasia, Cystic                47 (96%)     45 (90%)     44 (88%)     43 (86%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (50)         (50)         (50)                                   
      Myelofibrosis                                   18 (36%)     30 (60%)     20 (40%)     26 (52%)                               
      Myeloid Cell, Hyperplasia                        1 (2%)                                                                       
   Lymph Node                                         (8)          (12)         (11)         (15)                                   
      Lumbar, Hyperplasia, Lymphoid                    1 (13%)      1 (8%)                    2 (13%)                               
      Mediastinal, Atrophy                             1 (13%)                                                                      
      Mediastinal, Hyperplasia, Lymphoid               2 (25%)      5 (42%)      4 (36%)      4 (27%)                               
      Mediastinal, Infiltration Cellular,                                                                                           
        Histiocyte                                     1 (13%)                                                                      
      Mediastinal, Inflammation, Chronic Active        1 (13%)                                                                      
      Pancreatic, Hyperplasia, Lymphoid                                          2 (18%)      1 (7%)                                
      Pancreatic, Pigmentation                                                   1 (9%)                                             
      Renal, Hemorrhage                                             1 (8%)                    1 (7%)                                
      Renal, Hyperplasia, Lymphoid                                  3 (25%)                   1 (7%)                                
   Lymph Node, Mandibular                             (50)         (50)         (50)         (49)                                   
      Hyperplasia, Lymphoid                            4 (8%)      20 (40%)     12 (24%)      9 (18%)                               
   Lymph Node, Mesenteric                             (50)         (49)         (49)         (50)                                   
      Hyperplasia, Lymphoid                            6 (12%)     12 (24%)      6 (12%)      4 (8%)                                
   Spleen                                             (50)         (50)         (50)         (50)                                   
      Hematopoietic Cell Proliferation                16 (32%)     35 (70%)     32 (64%)     27 (54%)                               
      Hemorrhage                                                                              2 (4%)                                
      Inflammation, Chronic Active                                                            1 (2%)                                
      Necrosis                                                                                1 (2%)                                
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    5                                                              
                                                                                                                                   
NTP Experiment-Test: 88138-04         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                            BENZOPHENONE                                       Date: 06/01/04    
Route: DOSED FEED                                                                                                 Time: 13:24:25    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE FEMALE                        0 PPM        312 PPM      625 PPM      1250 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Lymphoid Follicle, Hyperplasia, Lymphoid        24 (48%)     36 (72%)     37 (74%)     22 (44%)                               
   Thymus                                             (46)         (50)         (50)         (50)                                   
      Atrophy                                          8 (17%)      7 (14%)      3 (6%)      13 (26%)                               
      Cyst                                            23 (50%)     35 (70%)     31 (62%)     24 (48%)                               
      Ectopic Parathyroid Gland                        1 (2%)       3 (6%)       1 (2%)       1 (2%)                                
      Hyperplasia, Lymphoid                                         8 (16%)      5 (10%)      2 (4%)                                
      Infiltration Cellular, Mast Cell                                           1 (2%)                                             
      Inflammation, Chronic Active                     1 (2%)                                                                       
      Thymocyte, Necrosis                                           1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Skin                                               (50)         (50)         (50)         (50)                                   
      Subcutaneous Tissue, Fibrosis                                 1 (2%)                                                          
      Subcutaneous Tissue, Infiltration Cellular,                                                                                   
         Lymphoid                                                   4 (8%)       1 (2%)                                             
      Subcutaneous Tissue, Infiltration Cellular,                                                                                   
         Polymorphonuclear                             1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (50)         (50)         (50)         (50)                                   
      Maxilla, Fracture                                                                       1 (2%)                                
   Skeletal Muscle                                    (2)          (4)          (2)          (4)                                    
      Infiltration Cellular, Lymphoid                               3 (75%)      2 (100%)                                           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (50)         (50)         (50)                                   
      Hemorrhage                                                                              2 (4%)                                
      Infiltration Cellular, Lymphoid                               1 (2%)       2 (4%)                                             
      Inflammation, Chronic Active                                                            1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (50)         (50)         (50)                                   
      Foreign Body                                     1 (2%)                                                                       
      Infiltration Cellular, Lymphoid                 33 (66%)     44 (88%)     44 (88%)     35 (70%)                               
      Inflammation, Chronic Active                                  1 (2%)       1 (2%)                                             
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    6                                                              
                                                                                                                                   
NTP Experiment-Test: 88138-04         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                            BENZOPHENONE                                       Date: 06/01/04    
Route: DOSED FEED                                                                                                 Time: 13:24:25    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE FEMALE                        0 PPM        312 PPM      625 PPM      1250 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
RESPIRATORY SYSTEM - CONT                                                                                                           
      Metaplasia, Osseous                                                                     1 (2%)                                
      Pigmentation                                                                            2 (4%)                                
      Alveolar Epithelium, Hyperplasia                 1 (2%)       1 (2%)       2 (4%)       2 (4%)                                
      Alveolus, Hemorrhage                             2 (4%)                                 3 (6%)                                
      Alveolus, Infiltration Cellular, Histiocyte      1 (2%)                                 2 (4%)                                
      Mediastinum, Inflammation, Chronic Active        1 (2%)                                                                       
   Nose                                               (50)         (50)         (50)         (50)                                   
      Hemorrhage                                                                              1 (2%)                                
      Inflammation, Chronic Active                     1 (2%)                    1 (2%)       1 (2%)                                
      Nasolacrimal Duct, Inflammation, Chronic                                                                                      
        Active                                         1 (2%)                                                                       
      Olfactory Epithelium, Metaplasia                                                       39 (78%)                               
   Trachea                                            (50)         (50)         (50)         (50)                                   
      Glands, Cyst                                                  1 (2%)                                                          
      Glands, Inflammation, Chronic Active                          1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (50)         (50)         (50)         (50)                                   
      Atrophy                                          2 (4%)                                                                       
      Lens, Cataract                                                             1 (2%)                                             
   Harderian Gland                                    (50)         (50)         (50)         (49)                                   
      Hyperplasia                                                   3 (6%)       3 (6%)       1 (2%)                                
      Infiltration Cellular, Lymphoid                 29 (58%)     27 (54%)     27 (54%)     23 (47%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (50)         (50)         (50)                                   
      Accumulation, Hyaline Droplet                                              1 (2%)       1 (2%)                                
      Atrophy                                          1 (2%)                                                                       
      Glomerulosclerosis                                                                      1 (2%)                                
      Hydronephrosis                                   2 (4%)                                 1 (2%)                                
      Infarct                                          4 (8%)       1 (2%)       3 (6%)       3 (6%)                                
      Infiltration Cellular, Lymphoid                 41 (82%)     45 (90%)     43 (86%)     39 (78%)                               
      Inflammation, Chronic Active                     1 (2%)                                                                       
      Metaplasia, Osseous                              1 (2%)       2 (4%)       4 (8%)       2 (4%)                                
      Mineralization                                  15 (30%)     31 (62%)     36 (72%)     49 (98%)                               
      Nephropathy                                     21 (42%)     33 (66%)     31 (62%)     30 (60%)                               
      Artery, Inflammation, Chronic Active             1 (2%)                                 1 (2%)                                
      Cortex, Cyst                                                  1 (2%)                                                          
      Renal Tubule, Pigmentation                       1 (2%)       1 (2%)       1 (2%)                                             
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    7                                                              
                                                                                                                                   
NTP Experiment-Test: 88138-04         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                            BENZOPHENONE                                       Date: 06/01/04    
Route: DOSED FEED                                                                                                 Time: 13:24:25    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE FEMALE                        0 PPM        312 PPM      625 PPM      1250 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
URINARY SYSTEM - CONT                                                                                                               
   Urinary Bladder                                    (50)         (49)         (50)         (50)                                   
      Infiltration Cellular, Lymphoid                 37 (74%)     38 (78%)     40 (80%)     39 (78%)                               
      Inflammation, Chronic Active                                                            1 (2%)                                
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                             Page    8                                                              
                                                                                                                                   
NTP Experiment-Test: 88138-04         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                            BENZOPHENONE                                       Date: 06/01/04    
Route: DOSED FEED                                                                                                 Time: 13:24:25    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE MALE                          0 PPM        312 PPM      625 PPM      1250 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
DISPOSITION SUMMARY                                                                                                                 
                                                                                                                                    
  Animals Initially In Study                          50           50           50           50                                     
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                 5            3            5            2                                     
    Natural Death                                      1            3            1            3                                     
  Survivors                                                                                                                         
    Terminal Sacrifice                                44           44           44           45                                     
                                                                                                                                    
  Animals Examined Microscopically                    50           50           50           50                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Gallbladder                                        (45)         (49)         (49)         (49)                                   
      Cyst                                                                       1 (2%)                                             
   Intestine Small, Jejunum                           (50)         (50)         (50)         (50)                                   
      Peyer's Patch, Hyperplasia, Lymphoid                                       1 (2%)                                             
   Liver                                              (50)         (50)         (50)         (50)                                   
      Basophilic Focus                                 4 (8%)       2 (4%)       5 (10%)                                            
      Clear Cell Focus                                 2 (4%)       7 (14%)      7 (14%)     12 (24%)                               
      Eosinophilic Focus                               5 (10%)      8 (16%)     11 (22%)     10 (20%)                               
      Fatty Change                                                               1 (2%)                                             
      Fibrosis                                                                   1 (2%)                                             
      Hematopoietic Cell Proliferation                 2 (4%)       1 (2%)                                                          
      Infarct                                                       2 (4%)                    1 (2%)                                
      Infiltration Cellular, Lymphoid                  6 (12%)     10 (20%)                   4 (8%)                                
      Inflammation, Chronic Active                    33 (66%)     47 (94%)     44 (88%)     42 (84%)                               
      Mixed Cell Focus                                 8 (16%)      9 (18%)     15 (30%)     13 (26%)                               
      Tension Lipidosis                                1 (2%)       1 (2%)                    1 (2%)                                
      Bile Duct, Cyst                                               3 (6%)                    1 (2%)                                
      Hepatocyte, Degeneration, Cystic                                           5 (10%)     30 (60%)                               
      Hepatocyte, Multinucleated                                   41 (82%)     47 (94%)     48 (96%)                               
      Hepatocyte, Necrosis                             1 (2%)       6 (12%)      8 (16%)      8 (16%)                               
      Hepatocyte, Vacuolization Cytoplasmic           44 (88%)     45 (90%)     46 (92%)     44 (88%)                               
      Hepatocyte, Centrilobular, Hypertrophy                       44 (88%)     50 (100%)    48 (96%)                               
      Oval Cell, Hyperplasia                                                     1 (2%)                                             
   Mesentery                                                       (2)          (8)          (5)                                    
      Fat, Fibrosis                                                 1 (50%)      5 (63%)      1 (20%)                               
      Fat, Inflammation, Chronic Active                             1 (50%)      5 (63%)      2 (40%)                               
      Fat, Mineralization                                           1 (50%)      3 (38%)                                            
      Fat, Necrosis                                                 1 (50%)      5 (63%)                                            
      Fat, Pigmentation                                             1 (50%)                                                         
   Pancreas                                           (50)         (50)         (50)         (50)                                   
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    9                                                              
                                                                                                                                   
NTP Experiment-Test: 88138-04         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                            BENZOPHENONE                                       Date: 06/01/04    
Route: DOSED FEED                                                                                                 Time: 13:24:25    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE MALE                          0 PPM        312 PPM      625 PPM      1250 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Cyst                                                                       1 (2%)       2 (4%)                                
      Cytoplasmic Alteration                           1 (2%)                                                                       
      Infiltration Cellular, Lymphoid                 14 (28%)     11 (22%)      8 (16%)      8 (16%)                               
      Acinus, Atrophy                                               1 (2%)       1 (2%)       1 (2%)                                
      Acinus, Cytoplasmic Alteration                                             1 (2%)                                             
   Salivary Glands                                    (50)         (50)         (50)         (50)                                   
      Atrophy                                                       1 (2%)                                                          
      Infiltration Cellular, Lymphoid                 31 (62%)     40 (80%)     40 (80%)     28 (56%)                               
   Stomach, Forestomach                               (50)         (50)         (50)         (50)                                   
      Hyperplasia                                                   1 (2%)                                                          
      Inflammation, Chronic Active                     1 (2%)       2 (4%)                                                          
      Epithelium, Cyst                                              1 (2%)                                                          
      Epithelium, Hyperkeratosis                       1 (2%)       2 (4%)       1 (2%)       1 (2%)                                
      Epithelium, Hyperplasia, Squamous                1 (2%)       2 (4%)       1 (2%)       1 (2%)                                
      Epithelium, Ulcer                                1 (2%)       1 (2%)                                                          
   Stomach, Glandular                                 (50)         (50)         (50)         (50)                                   
      Glands, Ectasia                                  7 (14%)     13 (26%)     18 (36%)      5 (10%)                               
      Glands, Mineralization                                                     1 (2%)       1 (2%)                                
   Tooth                                              (20)         (31)         (33)         (21)                                   
      Inflammation, Chronic Active                     1 (5%)                    3 (9%)                                             
      Malformation                                     3 (15%)      1 (3%)       3 (9%)                                             
      Gingiva, Inflammation, Chronic Active           18 (90%)     30 (97%)     32 (97%)     20 (95%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (50)         (50)         (50)         (50)                                   
      Hyperplasia, Atypical                                                                   1 (2%)                                
      Inflammation, Chronic Active                     3 (6%)       5 (10%)      3 (6%)       3 (6%)                                
      Mineralization                                   1 (2%)                                 1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (50)         (50)         (50)         (50)                                   
      Degeneration, Fatty                                                        2 (4%)                                             
      Hyperplasia                                      7 (14%)     10 (20%)      9 (18%)      6 (12%)                               
      Hypertrophy                                     26 (52%)     22 (44%)     24 (48%)     18 (36%)                               
      Inflammation, Chronic Active                                               1 (2%)                                             
      Necrosis                                                      1 (2%)                                                          
      Subcapsular, Hyperplasia                        50 (100%)    46 (92%)     46 (92%)     47 (94%)                               
   Adrenal Medulla                                    (50)         (50)         (50)         (50)                                   
      Hyperplasia                                                   1 (2%)                                                          
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page   10                                                              
                                                                                                                                   
NTP Experiment-Test: 88138-04         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                            BENZOPHENONE                                       Date: 06/01/04    
Route: DOSED FEED                                                                                                 Time: 13:24:25    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE MALE                          0 PPM        312 PPM      625 PPM      1250 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
   Islets, Pancreatic                                 (50)         (50)         (50)         (50)                                   
      Hyperplasia                                      1 (2%)       1 (2%)                                                          
   Pituitary Gland                                    (48)         (49)         (50)         (50)                                   
      Pars Distalis, Cyst                              7 (15%)      5 (10%)      5 (10%)      4 (8%)                                
      Pars Distalis, Hyperplasia                       1 (2%)       1 (2%)                                                          
      Pars Nervosa, Cyst                                            1 (2%)                                                          
   Thyroid Gland                                      (50)         (50)         (50)         (50)                                   
      Infiltration Cellular, Lymphoid                                            1 (2%)       1 (2%)                                
      Inflammation, Chronic Active                     2 (4%)                                                                       
      Follicle, Cyst                                   2 (4%)                                 1 (2%)                                
      Follicle, Degeneration                          12 (24%)      9 (18%)      6 (12%)      6 (12%)                               
      Follicular Cell, Hyperplasia                                               1 (2%)       1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Epididymis                                         (50)         (50)         (50)         (50)                                   
      Degeneration                                                  1 (2%)                                                          
      Granuloma Sperm                                  1 (2%)       2 (4%)       2 (4%)       1 (2%)                                
      Infiltration Cellular, Lymphoid                 32 (64%)     27 (54%)     30 (60%)     31 (62%)                               
      Mineralization                                                             4 (8%)                                             
      Spermatocele                                                               1 (2%)                                             
   Preputial Gland                                    (50)         (50)         (50)         (50)                                   
      Inflammation, Chronic Active                    21 (42%)     23 (46%)     25 (50%)     32 (64%)                               
      Duct, Ectasia                                   20 (40%)     15 (30%)     15 (30%)     28 (56%)                               
   Prostate                                           (50)         (50)         (50)         (50)                                   
      Infiltration Cellular, Lymphoid                 32 (64%)     43 (86%)     46 (92%)     28 (56%)                               
      Inflammation, Chronic Active                     1 (2%)                                                                       
      Artery, Inflammation, Chronic Active                          1 (2%)                    1 (2%)                                
   Seminal Vesicle                                    (50)         (50)         (50)         (50)                                   
      Artery, Inflammation, Chronic Active             1 (2%)                                                                       
   Testes                                             (50)         (50)         (50)         (50)                                   
      Mineralization                                                1 (2%)       4 (8%)      12 (24%)                               
      Germinal Epithelium, Degeneration                             3 (6%)       1 (2%)       2 (4%)                                
      Rete Testes, Cyst                                             1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                                                                                                    
                                                             Page   11                                                              
                                                                                                                                   
NTP Experiment-Test: 88138-04         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                            BENZOPHENONE                                       Date: 06/01/04    
Route: DOSED FEED                                                                                                 Time: 13:24:25    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE MALE                          0 PPM        312 PPM      625 PPM      1250 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (49)         (50)         (50)         (50)                                   
      Myeloid Cell, Hyperplasia                                                  1 (2%)                                             
   Lymph Node                                         (1)          (1)          (3)          (5)                                    
      Deep Cervical, Hyperplasia, Lymphoid                                       1 (33%)                                            
      Mediastinal, Hyperplasia, Lymphoid                            1 (100%)     1 (33%)                                            
      Mediastinal, Infiltration Cellular,                                                                                           
        Histiocyte                                     1 (100%)                                                                     
      Mediastinal, Inflammation, Granulomatous                                                1 (20%)                               
   Lymph Node, Mandibular                             (48)         (50)         (49)         (47)                                   
      Hyperplasia, Lymphoid                            5 (10%)      1 (2%)       6 (12%)      5 (11%)                               
   Lymph Node, Mesenteric                             (49)         (50)         (49)         (48)                                   
      Hyperplasia, Lymphoid                            2 (4%)       2 (4%)                    2 (4%)                                
      Infiltration Cellular, Histiocyte                1 (2%)                                                                       
      Inflammation, Granulomatous                                                             1 (2%)                                
   Spleen                                             (50)         (50)         (50)         (50)                                   
      Angiectasis                                                                1 (2%)                                             
      Hematopoietic Cell Proliferation                11 (22%)      7 (14%)      9 (18%)     14 (28%)                               
      Lymphoid Follicle, Hyperplasia, Lymphoid        17 (34%)     31 (62%)     34 (68%)     32 (64%)                               
   Thymus                                             (46)         (48)         (46)         (47)                                   
      Atrophy                                         12 (26%)      9 (19%)      6 (13%)      5 (11%)                               
      Cyst                                            16 (35%)     25 (52%)     20 (43%)     20 (43%)                               
      Ectopic Parathyroid Gland                        2 (4%)                                                                       
      Ectopic Thyroid                                                            1 (2%)                                             
      Infiltration Cellular, Histiocyte                1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Skin                                               (50)         (50)         (50)         (50)                                   
      Cyst Epithelial Inclusion                                                               1 (2%)                                
      Inflammation, Granulomatous                      1 (2%)                                                                       
      Mineralization                                                                          1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Spinal Cord                                        (1)          (1)          (1)                                                 
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page   12                                                              
                                                                                                                                   
NTP Experiment-Test: 88138-04         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                            BENZOPHENONE                                       Date: 06/01/04    
Route: DOSED FEED                                                                                                 Time: 13:24:25    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE MALE                          0 PPM        312 PPM      625 PPM      1250 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
NERVOUS SYSTEM - CONT                                                                                                               
      Degeneration                                     1 (100%)                                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (50)         (50)         (50)                                   
      Infiltration Cellular, Lymphoid                 32 (64%)     38 (76%)     47 (94%)     36 (72%)                               
      Inflammation, Chronic Active                     1 (2%)       2 (4%)       1 (2%)       1 (2%)                                
      Metaplasia, Osseous                                                        1 (2%)                                             
      Necrosis                                         1 (2%)                                                                       
      Thrombosis                                                    1 (2%)                                                          
      Alveolar Epithelium, Hyperplasia                 6 (12%)      7 (14%)      8 (16%)      4 (8%)                                
      Alveolus, Infiltration Cellular, Histiocyte      7 (14%)      1 (2%)       1 (2%)       3 (6%)                                
      Mediastinum, Inflammation, Suppurative                                     1 (2%)                                             
   Nose                                               (50)         (50)         (50)         (50)                                   
      Inflammation, Chronic Active                     2 (4%)                    1 (2%)       2 (4%)                                
      Inflammation, Focal, Suppurative                                                        1 (2%)                                
      Inflammation, Suppurative                                                  1 (2%)                                             
      Nasolacrimal Duct, Inflammation, Chronic                                                                                      
        Active                                                                   2 (4%)       1 (2%)                                
      Olfactory Epithelium, Degeneration               1 (2%)                                                                       
      Olfactory Epithelium, Metaplasia                              2 (4%)       2 (4%)      24 (48%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (50)         (50)         (50)         (50)                                   
      Inflammation, Suppurative                                                  1 (2%)                                             
      Anterior Chamber, Iris, Inflammation,                                                                                         
        Suppurative                                                 1 (2%)                                                          
      Cornea, Inflammation, Chronic Active                          1 (2%)       2 (4%)       1 (2%)                                
   Harderian Gland                                    (50)         (50)         (50)         (50)                                   
      Hyperplasia                                      2 (4%)       3 (6%)       3 (6%)       2 (4%)                                
      Infiltration Cellular, Lymphoid                 37 (74%)     33 (66%)     24 (48%)     29 (58%)                               
      Inflammation, Chronic Active                     1 (2%)                    1 (2%)                                             
      Mineralization                                                                          1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (50)         (50)         (50)                                   
      Infarct                                          1 (2%)       1 (2%)       1 (2%)       4 (8%)                                
      Infiltration Cellular, Lymphoid                 44 (88%)     44 (88%)     45 (90%)     45 (90%)                               
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page   13                                                              
                                                                                                                                   
NTP Experiment-Test: 88138-04         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                            BENZOPHENONE                                       Date: 06/01/04    
Route: DOSED FEED                                                                                                 Time: 13:24:25    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE MALE                          0 PPM        312 PPM      625 PPM      1250 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
URINARY SYSTEM - CONT                                                                                                               
      Inflammation, Chronic Active                                  1 (2%)       2 (4%)                                             
      Metaplasia, Osseous                              4 (8%)       2 (4%)       1 (2%)       8 (16%)                               
      Mineralization                                  49 (98%)     50 (100%)    50 (100%)    50 (100%)                              
      Necrosis                                                                   1 (2%)                                             
      Nephropathy                                     49 (98%)     48 (96%)     50 (100%)    50 (100%)                              
      Artery, Inflammation, Chronic Active             1 (2%)       1 (2%)                                                          
      Cortex, Cyst                                     4 (8%)       8 (16%)     12 (24%)     22 (44%)                               
      Renal Tubule, Pigmentation                                                              1 (2%)                                
   Urinary Bladder                                    (50)         (50)         (50)         (50)                                   
      Infiltration Cellular, Lymphoid                 24 (48%)     24 (48%)     32 (64%)     23 (46%)                               
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                             Page   14                                                              
                                                                                                                                   
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------